1. (a) To be a covered vaccine product, a vaccine product must be one

   1. (1) for which the United States Food and Drug Administration (FDA) requires a national drug code (NDC) number; and
   2. (2) that is listed electronically with the FDA.

2. (b) The department will pay for the following vaccine services provided by a provider who is acting within the scope of the individual's license or certificate to practice:

   1. (1) a vaccine product for a recipient under 21 years of age, unless the product is available at no cost to the provider;
   2. (2) the administration of a vaccine product to a recipient under 21 years of age;

   3. (3) for a recipient 21 years of age or older, the following vaccine products, unless they are available at no cost to the provider, and the administration of those vaccine products, regardless of whether they are available at no cost to the provider:

      1. (A) Hepatitis A;
      2. (B) Hepatitis B;
      3. (C) Herpes Zoster (Shingles);
      4. (D) Human Papillomavirus;
      5. (E) Measles, Mumps, and Rubella (MMR);
      6. (F) Meningococcal;
      7. (G) Pneumococcal;
      8. (H) seasonal Influenza;
      9. (I) Tetanus Diphtheria (Td);
      10. (J) Tetanus, Diphtheria, and Acellular Pertussis (Tdap);
      11. (K) Varicella (Chickenpox);
      12. (L) Haemophilus Influenzae Type B;
      13. (M) post-exposure rabies vaccine or immune globulin;
      14. (N) pandemic influenza;

      15. (O) a vaccine product, and administration of a vaccine product, related to

          1. (i) a state public health disaster emergency declared by the governor under AS 26.23.020; or
          2. (ii) a federally declared public health emergency.

3. (c) The department will not pay for the following vaccine services:

   1. (1) vaccine products and administration for the sole purpose of international travel; and
   2. (2) pre-exposure rabies vaccine product and administration.

(Eff. 1/10/2021, Register 237)